Cargando…
Genetics and management of locally advanced carcinomas of the head and neck: role of altered fractionation radiotherapy
Squamous cell carcinoma of the head and neck (SCCHN) accounts for 5–7% of all malignancies. About 60% of newly diagnosed SCCHN are detected as locally advanced disease. Chemoradiation is a standard option and response rate to it is variable. Recently, a genetic classification of SCCHN has been propo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331692/ https://www.ncbi.nlm.nih.gov/pubmed/30652016 http://dx.doi.org/10.4155/fsoa-2018-0058 |